| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/30/2000 | EP1031627A1 Beta-carotene 15,15'-dioxygenase |
| 08/30/2000 | EP1030923A2 Method for producing virus-like particles on the basis of polyoma viruses |
| 08/30/2000 | EP1030918A2 Slit polypeptide and method of modulation of robo with ligands |
| 08/30/2000 | EP1030916A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis |
| 08/30/2000 | EP1030915A1 A novel gene and uses therefor |
| 08/30/2000 | EP1030911A1 Human aspartic proteases |
| 08/30/2000 | EP1030865A2 Th2 CELL DEPLETION; COMPOSITIONS; METHODS |
| 08/30/2000 | EP1030862A1 Viral clearance process |
| 08/30/2000 | EP1030859A1 Ras-binding protein (pre1) |
| 08/30/2000 | EP1030858A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport |
| 08/30/2000 | EP1030685A2 Essential bacterial genes and their use |
| 08/30/2000 | EP1030684A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response |
| 08/30/2000 | EP1030683A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 08/30/2000 | EP1030674A1 METHODS FOR TREATMENT OF TUMORS AND TUMOR CELLS USING $i(EX VIVO) ACTIVATED T CELLS |
| 08/30/2000 | EP0918845A4 Cleavable signal element device and method |
| 08/30/2000 | EP0671946B1 Immunoreactive peptides from epstein-barr virus |
| 08/30/2000 | EP0642348B1 Antibiotic cryptdin peptides and methods of their use |
| 08/30/2000 | EP0631501B1 Glycosylation-mediated inhibition of factor x |
| 08/30/2000 | EP0584287B1 Purification of müllerian inhibiting substance for treatment of certain tumors |
| 08/30/2000 | EP0573605B1 Preparation of factor ix |
| 08/30/2000 | CN1264741A Human adenosine-diphosphate ribosyglucose hydrolase protein and its coding sequence |
| 08/30/2000 | CN1055933C Polyclonal antibody, preparing process and use thereof |
| 08/29/2000 | USRE36844 Cellular attachment to trans-epithelial appliances |
| 08/29/2000 | US6111166 Transgenic mice expressing human Fcα and β receptors |
| 08/29/2000 | US6111091 Nucleotide sequence of ionotropic glutamate receptor; probes to identify and isolate related human receptor subunits; drug screening assays to identify agonists, antagonists, and modulators |
| 08/29/2000 | US6111089 Nucleic acid encoding a defined mouse amino acid sequence of a protein involved in embryo implantation; vaccine can be used as antifertility agent |
| 08/29/2000 | US6111088 Nucleotide sequence encoding a 52 kDa Ro/SSA autoantigen |
| 08/29/2000 | US6111080 Hybridoma cell line like b6h12, atcc hb 9771; produces antibodies which recognize integrin receptor that binds to proteins containing amino acid sequence arginine-glycine-aspartic acid; suppresses phagocytosis enhancement |
| 08/29/2000 | US6111079 Lead binding polypeptides and nucleotides coding therefore |
| 08/29/2000 | US6111076 Human G-protein coupled receptor (HIBCD07) |
| 08/29/2000 | US6111074 Amino acid sequence of polypeptide from the uridine monophosphate kinase family; for screening bactericides and bacteriostats; for diagnosis and prophylaxis of infections |
| 08/29/2000 | US6111071 Recombinant fusion protein comprising PDC-E2, BCOADC-E2 and OGDC-E2 and uses thereof |
| 08/29/2000 | US6110900 Nucleic acid ligands |
| 08/29/2000 | US6110899 LICC of Streptococcus pneumoniae |
| 08/29/2000 | US6110747 Compounds and methods for modulating tissue permeability |
| 08/29/2000 | US6110719 Phytase |
| 08/29/2000 | US6110705 Recombinant Chlamydia trachomatis pgp3 fusion protein |
| 08/29/2000 | US6110701 DNA encoding precursor of interleukin-1β converting enzyme--related cysteine proteinase II (ICErel -II) |
| 08/29/2000 | US6110700 Nucleic acids that code a modulator of kinase activity; for the diagnosis tumorous condition; for development of models for the evaluation cancer in organ and tissues |
| 08/29/2000 | US6110689 Method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen |
| 08/29/2000 | US6110687 Detection of antigens via oligonucleotide antibody conjugates |
| 08/29/2000 | US6110686 DNA hybridizing to a human cystatin-like protein (CSTIN) |
| 08/29/2000 | US6110672 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/29/2000 | US6110662 HTLV-I/HTLV-II assay and method |
| 08/29/2000 | US6110470 Dna molecules with encoded polypeptides with amino acid sequences |
| 08/29/2000 | US6110468 Respiratory syndrome virus for swine |
| 08/29/2000 | US6110467 Isolated porcine respiratory and reproductive virus, vaccines and methods of protecting a pig against a disease caused by a porcine respiratory and reproductive virus |
| 08/29/2000 | US6110463 Anti-Cryptosporidium parvum preparations |
| 08/29/2000 | CA2010164C Anthracycline immunoconjugates having a novel linker and methods for their production |
| 08/29/2000 | CA1341090C Vampire bat plasminogen activators |
| 08/26/2000 | CA2296792A1 Expressed sequence tags and encoded human proteins |
| 08/25/2000 | CA2300692A1 Sequence-determined dna fragments and corresponding polypeptides encoded thereby |
| 08/24/2000 | WO2000049144A2 Pyk2 binding proteins |
| 08/24/2000 | WO2000049139A2 A caspase activated protein kinase |
| 08/24/2000 | WO2000049051A1 Human adenosine a2b anti-receptor polyclonal antibodies |
| 08/24/2000 | WO2000049050A2 Use of blocking anti-tsh-receptor-antibodies in the therapy of hyperthyreoses and monoclonal antibodies for a use of this type |
| 08/24/2000 | WO2000049049A1 An antigen test to detect equine protozoal myeloencephalitis in horse serum and cerebrospinal fluid |
| 08/24/2000 | WO2000049048A1 Ndae1 - a new bicarbonate transporter |
| 08/24/2000 | WO2000049043A2 Human lipid-associated proteins |
| 08/24/2000 | WO2000049038A2 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 08/24/2000 | WO2000048681A2 Co-administration of a thrombolytic and an anti-cd18 antibody |
| 08/24/2000 | WO2000048638A2 Multi-mutant diphtheria toxin vaccines |
| 08/24/2000 | WO2000048633A1 Antibodies against hydrophobic proteins that are protective against candidiasis |
| 08/24/2000 | WO2000048631A2 Adjuvant and cell maturation agent |
| 08/24/2000 | WO2000048620A1 Yeast cell wall peptides and antibodies thereto |
| 08/24/2000 | WO2000031126A3 Suppression of xenotransplant rejection |
| 08/24/2000 | WO2000020434A9 Cadherin-like asymmetry protein-1, and methods for its use |
| 08/24/2000 | WO2000015797A3 Compositions and methods for the treatment of immune related diseases |
| 08/24/2000 | WO2000015796A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/24/2000 | WO2000015772A9 Recombinant protein production in urine |
| 08/24/2000 | WO2000012685A3 Genes associated with neurotransmitter processing |
| 08/24/2000 | WO2000009754A3 HUMAN STEAROYL-CoA DESATURASE-RELATED COMPOSITIONS AND METHODS FOR TREATING SKIN DISORDERS |
| 08/24/2000 | WO1999057280A3 Neisseria meningitidis antigens and compositions |
| 08/24/2000 | WO1999042828A3 Treating cancer |
| 08/24/2000 | WO1998024898A3 Therapeutic composition comprising the kal protein and use of the kal protein |
| 08/24/2000 | DE4193302C2 Verwendung rekombinanter Antikörper spezifisch für TNF-alpha Using recombinant antibody specific for TNF-alpha |
| 08/24/2000 | CA2645398A1 Universal plasma from antibodies-depleted blood |
| 08/24/2000 | CA2371799A1 Yeast cell wall peptides and antibodies thereto |
| 08/24/2000 | CA2362943A1 Pyk2 binding proteins |
| 08/24/2000 | CA2362936A1 A caspase activated protein kinase |
| 08/24/2000 | CA2362807A1 Multi-mutant diphtheria toxin vaccines |
| 08/24/2000 | CA2362300A1 Human lipid-associated proteins |
| 08/24/2000 | CA2359075A1 An antigen test to detect equine protozoal myeloencephalitis in horse serum and cerebrospinal fluid |
| 08/24/2000 | CA2262056A1 Composition, methods and reagents for the synthesis of a soluble form of human pex |
| 08/23/2000 | EP1029917A1 The LTR region of MSRV-1 and the proteins it encodes, and probes and methods for detecting MSRV-1 retrovirus |
| 08/23/2000 | EP1029870A2 Hybrid Immunoglobulins |
| 08/23/2000 | EP1029550A1 Preventives and remedies for diffuse lung diseases |
| 08/23/2000 | EP1029246A1 A method and device for preventing immunoglobulin degradation in external secretions |
| 08/23/2000 | EP1029082A2 DETECTION AND TYPING OF THE $i(iceA) GENE OF $i(HELICOBACTER PYLORI) |
| 08/23/2000 | EP1029064A1 Protein production in transgenic alfalfa plants |
| 08/23/2000 | EP1029058A1 Dna demethylase, therapeutic and diagnostic uses thereof |
| 08/23/2000 | EP1029057A1 Reovirus-derived proteins, nucleic acids encoding same, and uses therefor |
| 08/23/2000 | EP1029054A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene |
| 08/23/2000 | EP1029052A2 Neisserial antigens |
| 08/23/2000 | EP1029051A1 Genes with restricted expression in mesencephalic dopaminergic neurons |
| 08/23/2000 | EP1029049A2 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
| 08/23/2000 | EP1029046A2 Wnt-1 inducible genes |
| 08/23/2000 | EP1029045A2 EXTENDED cDNAs FOR SECRETED PROTEINS |
| 08/23/2000 | EP1029043A1 Human receptor proteins; related reagents and methods |
| 08/23/2000 | EP1028979A1 Variable region fusion peptides that form effector complexes in the presence of antigen |